Diversified Healthcare Trust (NASDAQ:DHC)’s traded shares stood at 1.78 million during the latest session, with the company’s beta value hitting 2.17. At the last check today, the stock’s price was $2.69, to imply a decrease of -0.74% or -$0.02 in intraday trading. The DHC share’s 52-week high remains $4.24, putting it -57.62% down since that peak but still an impressive 25.28% since price per share fell to its 52-week low of $2.01. The company has a valuation of $649.03M, with an average of 1.1 million shares in intraday trading volume over the past 10 days and average of 1.03 million shares over the past 3 months.
Analysts have given a consensus recommendation of Strong Sell for Diversified Healthcare Trust (DHC), translating to a mean rating of 4.00. Of 1 analyst(s) looking at the stock, 0 analyst(s) give DHC a Sell rating. 0 of those analysts rate the stock as Overweight while 0 advise Hold as 0 recommend it as a Buy. 1 analyst(s) have given it an Underweight rating. Estimates put the company’s current-quarter earnings per share at -0.29.
Diversified Healthcare Trust (NASDAQ:DHC) trade information
After registering a -0.74% downside in the latest session, Diversified Healthcare Trust (DHC) has traded red over the past five days. The 5-day price performance for the stock is 8.47%, and 24.54% over 30 days. With these gigs, the year-to-date price performance is 16.96%. Short interest in Diversified Healthcare Trust (NASDAQ:DHC) saw shorts transact 7.05 million shares and set a 6.46 days time to cover.
The extremes give us $5 and $5 for target low and target high price respectively. As such, DHC has been trading -85.87% off suggested target high and -85.87% from its likely low.
Diversified Healthcare Trust (DHC) estimates and forecasts
The rating firms project that company’s revenue will grow 5.40% compared to the previous financial year.
Revenue forecast for the current quarter as set by 2 analysts is 370.97M. Meanwhile, for the current quarter, a total of 2 analyst(s) estimate revenue growth to 374.17M.Earnings reports from the last fiscal year show that sales brought in 361.54M and 370.78M respectively in the corresponding quarters. In this case, analysts estimate current quarter sales to rise 2.61% before jumping 0.92% in the following quarter.
DHC Dividends
Diversified Healthcare Trust has its next earnings report out in March. However, it is important to take into account that this dividend yield ratio is just an indicator to only serve the purpose of guidance. Investors interested to invest in the stock should ponder company’s other fundamental and operations related aspects too. Diversified Healthcare Trust has a forward dividend ratio of 0.04, with the share yield ticking at 1.49% to continue the rising pattern observed over the past year. The company’s average dividend yield trailing the past 5-year period is 3.31%.
Diversified Healthcare Trust (NASDAQ:DHC)’s Major holders
Diversified Healthcare Trust insiders hold 10.23% of total outstanding shares, with institutional holders owning 74.58% of the shares at 83.08% float percentage. In total, 74.58% institutions holds shares in the company, led by FLAT FOOTED LLC. As of 2024-06-30, the company held over 23.49 million shares (or 9.8193% of shares), all amounting to roughly $71.64 million.
The next major institution holding the largest number of shares is VANGUARD GROUP INC with 19.72 million shares, or about 8.245% of shares outstanding. As of the market price on 2024-06-30, these shares were worth $60.15 million.
We also have Vanguard Total Stock Market Index Fund and Vanguard Specialized-Real Estate Index Fund as the top two Mutual Funds with the largest holdings of the Diversified Healthcare Trust (DHC) shares. Going by data provided on Sep 30, 2024 , Vanguard Total Stock Market Index Fund holds roughly 6.81 shares. This is just over 2.82% of the total shares, with a market valuation of $18.4 million. Data from the same date shows that the other fund manager holds a little less at 6.65, or 2.76% of the shares, all valued at about 17.95 million.
